Read More

Avantor and Avantor Foundation Make a Difference by Providing Critical Health Services for Vulnerable Communities in Singapore

Singapore, Aug 24, 2022 - (ACN Newswire via SEAPRWire.com) - Avantor Foundation, Avantor's philanthropic arm, committed financial resources to healthcare charitable organizations, HealthServe and SATA CommHealth, as part of the Foundation's mission to provide healthcare to those in need. The grants will offer much-needed support to communities who would otherwise be unable to receive quality medical care. By identifying community needs and addressing them through these grants, the Avantor Foundation is able to contribute to the advancement of healthcare in Singapore and the region."As we continue to create a better world, grants like this demonstrate our commitment to providing healthcare to those in need," said Christophe Couturier, Executive Vice President, AMEA, Avantor and Board Member of the Avantor Foundation. "By working with SATA CommHealth and HealthServe, we want to connect and help communities, which deserve crucial assistance but are sometimes overlooked. The aid we are providing will address the critical unmet needs in healthcare and enable Science for Goodness, and ultimately create a lasting impact in our communities."SATA CommHealth, an organization which serves the...

Read More

Avantor Named Best Company for Upstream Processing and Single-Use Solutions at BMK 2022

Awards recognize Avantor innovations that allow the biopharmaceutical industry to bring therapies to market more efficientlyIncheon, Korea, June 30, 2022 - (ACN Newswire via SEAPRWire.com) - Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, acquired awards for the best company in upstream processing and single-use solutions at the Biologics Manufacturing Korea (BMK) 2022 conference.Sang Kyu Lee, Representative Director - Avantor Korea/Japan (Left), James Hwang, Head of Application, Asia, Middle East & Africa – Biopharma after receiving the Awards for Best Company in Single-use Solutions and Upstream Processing at BMK 2022This is the second consecutive year that Avantor has been recognized for its upstream processing capabilities, a testament to its ongoing investment and innovations including development of high-purity raw materials, reagents and differentiated cell culture processes. In single-use solutions, Avantor received the best company award for the third consecutive year. Avantor was recognized for strengthening production capabilities and establis...

Read More

Avantor Acquires RIM Bio; Expands Bioproduction Footprint into China

RADNOR, Pa. and SHANGHAI, June 2, 2021 - (ACN Newswire via SEAPRWire.com) - Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today that it has acquired RIM Bio, a leading China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications. RIM Bio provides a complete range of single-use products manufactured in ISO 7 Class 10,000 cleanroom facilities Rim Bio's proprietary technology provides single use bioprocess customers with differentiated product offerings RIM Bio's Changzhou, China facility is Avantor's first single-use production plant in the AMEA region, building on the company's existing global single-use manufacturing network in the Americas and Europe and greatly increasing capacity to meet growing global demand in bioprocessing. Avantor will leverage RIM Bio's proprietary technologies and best-in-class lead times to provide single-use customers with a differentiated offering. Dr. Ger Brophy, Executive Vice President, Biopharma Production at Avantor, said, "Adding RIM Bio...